Profil
John Elmo is the founder of Doe & Ingalls of North Carolina Operating LLC, which was founded in 1986.
He held the title of Director starting in 2010.
Currently, Mr. Elmo is a Partner at Blue Diamond Capital LLC.
In the past, he worked as a Principal at J.T.
Baker, Inc.
Aktive Positionen von John Elmo
| Unternehmen | Position | Beginn |
|---|---|---|
Blue Diamond Capital LLC
Blue Diamond Capital LLC Investment ManagersFinance Blue Diamond Capital invests in small and middle market companies located in the United States with a transaction amount of USD 5 to 200 million and with minimum EBITDA of USD 1 million and revenue of USD 5 to 100 million. The firm focuses on companies operating in the fields of life Science, advanced technology, manufacturing, distribution and industrial sectors. It provides buyout and growth transactions. It takes controlling interests and requires board seat. | Private Equity Investor | - |
Ehemalige bekannte Positionen von John Elmo
| Unternehmen | Position | Ende |
|---|---|---|
J.T. Baker, Inc.
J.T. Baker, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical products for hospitals | Corporate Officer/Principal | - |
Doe & Ingalls of North Carolina Operating LLC
Doe & Ingalls of North Carolina Operating LLC Wholesale DistributorsDistribution Services Distributes chemicals and related products | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
J.T. Baker, Inc.
J.T. Baker, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical products for hospitals | Health Technology |
Doe & Ingalls of North Carolina Operating LLC
Doe & Ingalls of North Carolina Operating LLC Wholesale DistributorsDistribution Services Distributes chemicals and related products | Distribution Services |
Blue Diamond Capital LLC
Blue Diamond Capital LLC Investment ManagersFinance Blue Diamond Capital invests in small and middle market companies located in the United States with a transaction amount of USD 5 to 200 million and with minimum EBITDA of USD 1 million and revenue of USD 5 to 100 million. The firm focuses on companies operating in the fields of life Science, advanced technology, manufacturing, distribution and industrial sectors. It provides buyout and growth transactions. It takes controlling interests and requires board seat. | Finance |
















